The World Health Organization (WHO) approved on Wednesday the emergency use of India’s Covaxin vaccine against COVID-19.
“The Technical Advisory Group, convened by WHO and made up of regulatory experts from around the world, has determined that the #Covaxin vaccine meets WHO standards for protection against #COVID19, that the benefit of the vaccine far outweighs risks & the vaccine can be used … WHO has granted emergency use listing to #COVAXIN (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of #COVID19,” the WHO wrote on Twitter.
The vaccine is recommended for use in two doses, with a dose interval of four weeks, in all age groups 18 and above.
“Available data on vaccination of pregnant women with the #Covaxin vaccine is insufficient to assess vaccine safety or efficacy in pregnancy; studies in pregnant women are planned,” the UN agency added.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.